insulin
FDA approves artificial pancreas developed by the University of Virginia
January 2, 2020Business Services, Medical Communications FDA, Pancreas, Type 1 diabetes, diabetes, insulin, type 2 diabetes
The FDA has approved an artificial pancreas system based on technology from the University of Virginia’s Center for Diabetes Technology. …
Eli Lilly CEO says Elizabeth Warren’s claims they failed on cheaper insulin is ‘nonsense’
December 18, 2019Research and Development Bernie Sanders, Eli Lilly, Elizabeth Warren, US Pharma, US Presidential Election, insulin
David Ricks, the CEO of Eli Lilly, has said that Presidential candidate Senator Elizabeth Warren’s claims his company failed on …
Sanofi to move away from diabetes and cardiovascular, as company shakeup continues
December 10, 2019Manufacturing and Production ASH 19, Sanofi, Sanofi Diabetes, Sanofi Insulin, diabetes, insulin
Sanofi has said it will stop investment and research into creating new diabetes and cardiovascular drugs, as part of the …
South Korea jails executives for their role in Samsung Biologics fraud
December 10, 2019Manufacturing and Production Samsung phones, Sanofi, Sanofi Diabetes, South Korea Healthcare System, South Korea Samsung, diabetes, inhaled insulin, insulin, south korea
Three executives of Samsung Electronics have been sentenced to jail for their role in committing fraud at its biotech affiliate …
Novo Nordisk set to launch price cut for insulin drug NovoLog after harsh criticism over prices in the US
September 9, 2019Sales and Marketing Novo Nordisk, NovoLog, insulin
Danish drug maker Novo Nordisk has said it will offer a generic version of NovoLog (insulin aspart) at a price …
Cost of insulin doubled between 2012 and 2016
January 23, 2019Research and Development USA, healthcare, insulin, insurance, pricing
The cost of insulin almost doubled in the United States between 2012 and 2016, according to a report by the …
Novo Nordisk stockpiles 16 weeks’ worth of insulin in preparation for hard Brexit
September 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Novo Nordisk, UK, brexit, insulin, pharma, stockpiles
Danish multinational Novo Nordisk has announced that they are increasing their stocks of insulin products to ensure that there are …
FDA approves first short-acting, follow-on biologic of Lilly’s Humalog insulin product
December 12, 2017Manufacturing and Production, Sales and Marketing Admelog, FDA, Humalog, Sanofi, diabetes, insulin, pharma
The FDA has announced its approval of Sanofi’s Admelog (insulin lispro), the first follow-on biologic version of Eli Lilly’s Humalog …
Sanofi launches patent infringement lawsuit against Mylan over diabetes pen
October 25, 2017Research and Development, Sales and Marketing Basaglar, Eli Lilly, Lantus, Mylan, Sanofi, diabetes, insulin, patent infringement, pharma
Sanofi has launched a lawsuit against Mylan as part of a dispute that alleges that the latter infringed upon 18 …
Pioneering immunotherapy halts progression of type 1 diabetes
August 10, 2017Research and Development Type 1 diabetes, diabetes, drugs, insulin, life sciences, medicines, pharma, pharmaceutical
In a first for the disease area, an immunotherapy treatment for diabetes, developed by researchers at King’s College London and …
Price-fixing class action lawsuit levelled at three major insulin producers
January 31, 2017Manufacturing and Production, Sales and Marketing Eli Lilly, Novo Nordisk, Sanofi, diabetes, insulin, price-fixing
A group of patients has filed a class action lawsuit in a federal court in Massachusetts, accusing three companies of …
Patients’ insulin pumps are revealed to be hackable by J&J
October 4, 2016Research and Development, Sales and Marketing FDA, Hackers, Johnson & Johnson, diabetes, insulin
Johnson & Johnson have begun warning patients that their insulin pumps, that patients attach to their bodies and are controlled …
Novo Nordisk to cut 2% of its entire workforce
September 29, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Denmark, Novo Nordisk, diabetes, insulin, job cuts, job losses
Novo Nordisk, headquartered in Bagsvaerd, Denmark, has taken the decision to lose 1,000 of its workforce from a total global …
Novo Nordisk to provide discounted insulin to poorest nations
September 23, 2016Medical Communications, Sales and Marketing Novo Nordisk, diabetes, insulin
Danish pharma firm Novo Nordisk has announced its intention to provide insulin at discounted prices to the world’s poorest nations …
MSD insulin glargine biosimilar meets primary endpoint in late-stage trials
June 14, 2016Manufacturing and Production, Research and Development, Sales and Marketing MSD, Merck, biosimilar, insulin, insuline glargine
MSD (NYSE: MRK), known as Merck in the US and Canada, has announced results from two Phase III studies evaluating …
Latest content
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner
